ENTITY
WuXi PharmaTech Cayman

WuXi PharmaTech Cayman (WX US)

32
Analysis
Health CareChina
WuXi PharmaTech (Cayman), Inc. provides research services. The Company offers services include researching, analysis, development, and manufacturing of pharmaceutical and biotechnology products.
more
17 Jul 2015 01:01

WuXi PharmaTech: How to Argue for a Few Dollars More

WuXi PharmaTech's recent placements of stock of its NEEQ-listed Syn-The-All Pharmaceutical Co. subsidiary have been at a substantially higher...

Share
09 Jul 2015 06:01

Who's Optimistic About Pharmacy's Future in China? China Nepstar's Controlling Shareholder

China Nepstar's Chairman and his China Neptunus Drugstore Holding Ltd. (54% owner) has offered $2.60/ADS to take the company private (announcement...

Share
01 Jul 2015 22:01

China ADR Privatizations: The Challenges of Getting the Best Deal

The stellar performance of China’s stock markets over the past twelve months (Shanghai +121%, Shenzhen +161%, and Hong Kong +17%) has led to a...

Share
01 May 2015 06:34

WuXi's Chairman and Ally Bridge Offer $46/ADS in Going Private Bid

WuXi's Founder, Chairman and CEO, Dr. Ge Li and private equity firm Ally Bridge have made a non-binding offer to take the company private for...

Share
21 Apr 2015 07:53

Increasing Opportunities in Emerging Market CROs

Life sciences R&D spending growth in Asia is outpacing the developed world (US, Canada, and Europe). An article from the January 2, 2014,...

Share
x